Teva-Buprenorphine/Naloxone 8 mg

TEVA-BUPRENORPHINE/NALOXONE 8 MG sublingual tablets combine buprenorphine and naloxone for opioid dependence management. Learn about its uses, effects, and precautions.

TEVA-BUPRENORPHINE/NALOXONE 8 MG tablets are commonly used for the treatment of opioid dependence. Buprenorphine, a partial opioid agonist, helps reduce withdrawal symptoms and cravings, while naloxone helps deter misuse. This combination is often prescribed as part of a comprehensive treatment plan for opioid addiction. The tablets are designed to be placed under the tongue (sublingually) for absorption.

Common effects of TEVA-BUPRENORPHINE/NALOXONE 8 MG tablets may include nausea, vomiting, headache, and constipation. Some users may experience dizziness or drowsiness. These effects can vary from person to person and typically subside as the body adjusts to the medication. Always consult a healthcare provider for personalized advice.

TEVA-BUPRENORPHINE/NALOXONE 8 MG tablets should be handled with care. They are intended for sublingual use only and should not be crushed, chewed, or swallowed. Keep the medication out of reach of children and pets. Store the tablets at room temperature, away from moisture and heat. Follow the prescribed dosage and administration instructions provided by your healthcare provider.

TEVA-BUPRENORPHINE/NALOXONE 8 MG tablets may interact with other medications, including other opioids, benzodiazepines, and certain antidepressants. Alcohol and other central nervous system depressants can enhance the sedative effects of buprenorphine. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.